» Articles » PMID: 9761740

Phosphatidylinositol 3'-kinase Associates with an Insulin Receptor Substrate-1 Serine Kinase Distinct from Its Intrinsic Serine Kinase

Overview
Journal Biochem J
Specialty Biochemistry
Date 1998 Oct 8
PMID 9761740
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Serine phosphorylation of insulin receptor substrate-1 (IRS-1) has been proposed as a counter-regulatory mechanism in insulin and cytokine signalling. Here we report that IRS-1 is phosphorylated by a wortmannin insensitive phosphatidylinositol 3'-kinase (PI 3-kinase)-associated serine kinase (PAS kinase) distinct from PI 3-kinase serine kinase. We found that PI 3-kinase immune complexes contain 5-fold more wortmannin-insensitive serine kinase activity than SH2-containing protein tyrosine phosphatase-2 (SHP2) and IRS-1 immune complexes. Affinity chromatography of cell lysates with a glutathione S-transferase fusion protein for the p85 subunit of PI 3-kinase showed that PAS kinase associated with the p85 subunit of PI 3-kinase. This interaction required unoccupied SH2 domain(s) but did not require the PI 3-kinase p110 subunit binding domain. In terms of function, PAS kinase phosphorylated IRS-1 and, after insulin stimulation, PAS kinase phosphorylated IRS-1 in PI 3-kinase-IRS-1 complexes. Phosphopeptide mapping showed that insulin-dependent in vivo sites of IRS-1 serine phosphorylation were comparable to those of PAS kinase phosphorylated IRS-1. More importantly, PAS kinase-dependent phosphorylation of IRS-1 reduced by 4-fold the ability of IRS-1 to act as an insulin receptor substrate. Taken together, these findings indicate that: (a) PAS kinase is distinct from the intrinsic serine kinase activity of PI 3-kinase, (b) PAS kinase associates with the p85 subunit of PI 3-kinase through SH2 domain interactions, and (c) PAS kinase is an IRS-1 serine kinase that can reduce the ability of IRS-1 to serve as an insulin receptor substrate.

Citing Articles

Photodynamic therapy activated signaling from epidermal growth factor receptor and STAT3: Targeting survival pathways to increase PDT efficacy in ovarian and lung cancer.

Edmonds C, Hagan S, Gallagher-Colombo S, Busch T, Cengel K Cancer Biol Ther. 2012; 13(14):1463-70.

PMID: 22986230 PMC: 3542238. DOI: 10.4161/cbt.22256.

References
1.
Cleveland D, Fischer S, Kirschner M, Laemmli U . Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis. J Biol Chem. 1977; 252(3):1102-6. View

2.
Carpenter C, Auger K, Duckworth B, Hou W, Schaffhausen B, Cantley L . A tightly associated serine/threonine protein kinase regulates phosphoinositide 3-kinase activity. Mol Cell Biol. 1993; 13(3):1657-65. PMC: 359478. DOI: 10.1128/mcb.13.3.1657-1665.1993. View

3.
Smith D, Johnson K . Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene. 1988; 67(1):31-40. DOI: 10.1016/0378-1119(88)90005-4. View

4.
Miyasaka T, Miyasaka J, Saltiel A . Okadaic acid stimulates the activity of microtubule associated protein kinase in PC-12 pheochromocytoma cells. Biochem Biophys Res Commun. 1990; 168(3):1237-43. DOI: 10.1016/0006-291x(90)91161-k. View

5.
Duclos B, Marcandier S, Cozzone A . Chemical properties and separation of phosphoamino acids by thin-layer chromatography and/or electrophoresis. Methods Enzymol. 1991; 201:10-21. DOI: 10.1016/0076-6879(91)01004-l. View